SCHEMBL8098657

SCHEMBL8098657

C[C@@H](CO)NC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccccc4)CCC3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HTT P42858 1/20 0.37
CA12 O43570 5/20 0.36
CA1 P00915 5/20 0.36
CA2 P00918 5/20 0.36
CA9 Q16790 5/20 0.36
GHSR Q92847 1/20 0.35
PIK3CD O00329 4/20 0.34
ROCK2 O75116 4/20 0.34
ROCK1 Q13464 4/20 0.34
PIK3CA P42336 1/20 0.34
NAMPT P43490 2/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP2C9 P11712 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098658 1.00 MAPT (0.37) MAPTKDM4EHTTCA12CA1
SCHEMBL8097581 0.97 MAPT (0.38) MAPTKDM4EHTTCA12CA1
SCHEMBL8092462 0.92 PIK3CA (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL8091845 0.92 PIK3CA (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL8106295 0.90 CA12 (0.42) MAPTKDM4EHTTCA12CA1
SCHEMBL8091937 0.88 CA12 (0.39) CA12CA1CA2CA9PIK3CD
SCHEMBL8096342 0.87 PIK3CA (0.41) MAPTKDM4EHTTPIK3CDPIK3CA
SCHEMBL8082578 0.86 PIK3CD (0.43) MAPTKDM4ECA12CA1CA2
SCHEMBL8089094 0.86 PIK3CD (0.43) MAPTKDM4ECA12CA1CA2
SCHEMBL8084013 0.85 PIK3CA (0.41) MAPTKDM4EHTTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed